Dan Nandan is the CEO of Staffingly, Inc. With 25+ years in IT consulting and a decade leading healthcare BPO operations across India, Latin America, and Pakistan, his team now serves 800+ U.S. healthcare providers across medical, dental, pharmacy, and post-acute care verticals.
2026 Compliance Verified: HIPAA, SOC 2 Type II, ISO 27001, HITRUST-aligned workflows.
Featured in Computerworld →
State of Illinois. Registered Professional Nurse
Bincy Shiiju Kuriakose is a U.S.-licensed Registered Nurse (MSN, RN), NCLEX-RN certified, with expertise in hospital nursing, telehealth, and nursing education. She reviews every publication for medical accuracy, YMYL compliance, and evidence-based clinical context.
What Are Drug Assistance Programs and Patient Responsibilities?
Drug assistance programs (DAPs), also called patient assistance programs (PAPs), help patients who cannot afford their medications get prescription drugs at reduced cost or no cost. They span federal, state, manufacturer, and nonprofit levels, and each has its own rules, eligibility requirements, and application process. Patient responsibilities are the conditions enrolled patients must meet to keep their benefits, such as annual income re-attestation, renewal deadlines, and reporting coverage changes. Missing them can cause loss of benefits and gaps in medication access. With 28% of adults struggling to pay for prescriptions (37% of those on 4+ medications, KFF 2024) and fewer than 10% of eligible patients actually reaching the programs built for them, managing these applications has become a heavy administrative load on practices.
RESEARCH
Key Stats:
- 28% of adults struggle to pay for prescription drugs; 37% for those on 4+ medications (KFF 2024)
- Over 900 public and private assistance programs searchable through PhRMA Medicine Assistance Tool (MAT)
- 340B covered entities purchased $81.4 billion in covered outpatient drugs in 2024; hospitals account for 87% of purchases (HRSA)
- 52.4% of practices spend 10-15 hours per week on PAP applications; 18.8% spend more than half of assigned staff time (PMC survey)
- Approximately 30% of adults did not take medications as prescribed in the past year due to cost (KFF/Pfizer 2024)
- Despite $5 billion annual manufacturer investment in PAPs, less than 10% of eligible patients actually access them (ProPharma/BioPharma Dive)
- Medicare Part D out-of-pocket cap: $2,100 for 2026; donut hole eliminated as of 2025 (ASPE/HHS)
- Medicare Extra Help caps Part D copays at $5.10 for generics and $12.65 for brand-name drugs in 2026; eligibility up to 150% FPL (CMS)
- Global healthcare BPO market: $423.1 billion in 2026 (MarketsandMarkets); US market: $165.05 billion, 8.26% CAGR (Mordor Intelligence)
State Notes (AZ/CO/WA):
- AZ: AHCCCS prescription copayment $2.30; Arizona Rx Card provides up to 80% discounts with no income requirement; AHCCCS updated BIN/PCN/Group IDs effective 1/1/2026; some manufacturers exited MDRP effective October 1, 2025
- CO: State Drug Assistance Program (SDAP) serves HIV-positive residents at or below 500% FPL; annual renewal required during birth month; Colorado Bridging the Gap SPAP assists Medicare-eligible residents
- WA: Prescription Drug Affordability Board (PDAB) selected Enbrel, Xtandi, Cabometyx, Humira for affordability reviews 2025; $35/month insulin copay cap for state-regulated health plans; Apple Health covers prescriptions for eligible residents
What Are Drug Assistance Programs?
Drug assistance programs help patients who cannot afford their medications get access to prescription drugs at reduced cost or no cost. These programs exist across federal, state, manufacturer, and nonprofit levels, and each has different rules, eligibility requirements, and application processes.
For healthcare practices, drug assistance programs are not just a patient benefit. They are an operational responsibility. Someone on your team has to identify which programs a patient qualifies for, complete the application, collect supporting documents, submit on time, and track renewals. That work adds up fast.
Here are the main types of drug assistance programs your practice needs to know:
Patient Assistance Programs (PAPs) Manufacturer-sponsored programs that provide brand-name medications for free or at very low cost to eligible patients. Most PAPs require patients to have income below 200-400% of the Federal Poverty Level, lack prescription drug coverage, and reside in the US. Over 900 programs are listed in the PhRMA Medicine Assistance Tool (MAT). Despite $5 billion in annual manufacturer investment, less than 10% of eligible patients actually enroll.
340B Drug Pricing Program The 340B program, administered by HRSA, requires drug manufacturers to sell outpatient drugs at significant discounts to eligible healthcare organizations (FQHCs, disproportionate share hospitals, Ryan White grantees, and other covered entities). In 2024, 340B covered entities purchased $81.4 billion in drugs under the program. Hospitals account for 87% of 340B purchases. The savings generated are supposed to be reinvested in patient care and expanded access.
Copay Assistance and Copay Cards Manufacturer copay cards reduce the out-of-pocket cost for commercially insured patients filling brand-name prescriptions. However, copay accumulator and maximizer programs used by some insurers and PBMs prevent copay card payments from counting toward the patient’s annual out-of-pocket maximum, leaving patients with unexpected costs mid-year. As of September 2024, 21 states plus DC have passed laws restricting these accumulator programs.
State Pharmaceutical Assistance Programs (SPAPs) Many states offer their own prescription drug assistance programs. These vary widely in eligibility, covered medications, and benefit structure. SPAP payments count toward Medicare Part D out-of-pocket maximums.
Medicare Extra Help (Low-Income Subsidy) This federal program caps Part D drug copays at $5.10 for generics and $12.65 for brand-name drugs in 2026. Eligibility extends to Medicare enrollees with income up to 150% FPL (about $23,940/year for an individual) and resources up to $16,590.
Nonprofit and Foundation Programs Organizations like the PAN Foundation, Patient Advocate Foundation, NeedyMeds, and disease-specific foundations provide copay assistance, premium assistance, and help connecting patients to other resources.
Patient Responsibilities in Drug Assistance Programs
Patients enrolled in drug assistance programs have specific responsibilities that, if missed, can result in loss of benefits, gaps in medication access, or compliance issues.
Completing the Application Accurately The patient portion of most PAP applications requires income documentation (tax returns, pay stubs, or Social Security statements), proof of residency, insurance status, and a signed attestation. Errors or missing documents are the most common reason applications are delayed or denied.
Annual Renewal and Income Reverification Most drug assistance programs require annual renewal. Patients must reverify their income and insurance status each year to maintain eligibility. Colorado’s SDAP, for example, requires members to renew during their birth month. Missing a renewal deadline means a gap in medication access until the patient reapplies and is approved.
Reporting Changes in Income or Insurance If a patient gains new insurance coverage, loses a job, or experiences a significant income change, most PAPs require the patient to report that change. Gaining commercial insurance or Medicare Part D may disqualify a patient from a manufacturer PAP. Practices that track these changes proactively can help patients transition to the appropriate assistance program without a coverage gap.
Submitting Out-of-Pocket Costs to Medicare For Medicare Part D enrollees receiving PAP assistance, CMS requires patients to submit their out-of-pocket costs to their Part D plan. If they do not submit these costs, the amounts will not count toward their annual drug spending totals.
Following Prescription and Refill Schedules Many PAPs ship medications directly to the patient or the practice on a set schedule. Patients must follow the prescribed refill cadence and notify the program or practice if they need adjustments. Stockpiling, missing refills, or failing to pick up shipments can trigger program termination.
Understanding Copay Card Limits Patients using manufacturer copay cards need to understand the annual maximum on their card. Once the card’s value is exhausted, the patient becomes responsible for the full copay or coinsurance amount. In states without copay accumulator protections, this can create a sudden mid-year cost spike that leads to medication abandonment.
Save 40-70% with dedicated Healthcare specialists
Book a 15-minute call. We will map your current healthcare outsourcing workflow, denial rates, and staff hours against what a dedicated team typically delivers in the first 30 days.
How Practices Manage Drug Assistance Programs
Managing drug assistance programs is not a clinical function. It is an administrative operation that requires dedicated staff, systematic tracking, and ongoing follow-up.
Step 1: Identifying Eligible Patients Staff screen patients for income level, insurance status, medication list, and diagnosis to determine which assistance programs may apply. For specialty drugs costing $5,000-$15,000 per month (IQVIA Institute 2024), this screening is critical to avoid medication abandonment before therapy even begins.
Step 2: Matching Patients to Programs With over 900 programs available through the PhRMA Medicine Assistance Tool alone, plus 340B, SPAPs, Extra Help, and nonprofit foundations, finding the right program for each patient requires research. Staff must compare eligibility thresholds, covered medications, application requirements, and benefit structures across multiple programs.
Step 3: Completing and Submitting Applications Each manufacturer has its own application form, submission method (fax, online portal, mail), and required documentation. The provider must complete a clinical section for most PAP applications. A PMC survey found that in 52.4% of practices, PAP applications consumed 10-15 hours per week of staff time. In 18.8% of practices, PAP work took more than half of the assigned staff member’s working hours.
Step 4: Tracking Approvals, Denials, and Shipments Once an application is submitted, someone must track whether it was approved, denied, or requires additional documentation. For denied patients, staff must identify an alternative program or appeal.
Step 5: Managing Renewals Every enrolled patient requires annual renewal. Staff must track renewal dates for each patient across every program, collect updated income documents, and resubmit applications before the deadline. A single missed renewal means the patient loses access until reapproval.
This workflow is why 28% of adults still struggle to afford their medications (KFF 2024) and why less than 10% of eligible patients enroll in available PAPs. The programs exist, but the operational burden of managing them at scale overwhelms most practice teams.
Challenges in PAP Enrollment and Drug Assistance Management
No Standardized Process Every manufacturer defines its own eligibility criteria, application form, submission method, and renewal timeline. Staff must learn and manage dozens of different processes simultaneously.
High Staff Time Per Application Completing a single PAP application takes an average of one hour of staff time per medication per patient per year (PMC practice survey). For a practice managing 50 patients on specialty medications, that is 50+ hours annually just on initial applications, not counting renewals, appeals, or tracking.
Clinical Staff Pulled Into Administrative Work In nearly 25% of practices surveyed, oncology nurses were the primary staff completing PAP applications (PMC). More than 50% of surveyed practices used highly paid clinical staff for PAP paperwork, pulling them away from patient care.
Copay Accumulator Complications When insurers use copay accumulator or maximizer programs, patients hit unexpected cost walls mid-year. Staff must then scramble to find alternative assistance, switch medications, or enroll the patient in a different program.
340B Compliance Complexity For 340B covered entities, drug assistance management adds another layer. Staff must ensure that 340B-acquired drugs are not duplicated with PAP-provided drugs for the same patient. HRSA issued an RFI (deadline April 20, 2026) on using rebates to enforce 340B ceiling prices.
2026 Regulatory Changes The IRA’s Part D redesign, Medicare drug price negotiations (10 drugs effective 2026), expanding state copay accumulator protections, and 340B policy shifts all affect which patients qualify for which programs and how assistance stacks.
Outsourcing Drug Assistance Program Management
Outsourcing the administrative side of drug assistance program management to a healthcare BPO partner removes the operational burden from your clinical team without reducing patient access to medication assistance.
What Gets Outsourced
- Patient eligibility screening for PAPs, 340B, SPAPs, Extra Help, and copay assistance
- Application completion (administrative sections) and document collection
- Submission tracking across manufacturer portals, fax, and mail
- Denial follow-up and alternative program identification
- Renewal calendar management and proactive reverification
- Shipment tracking and patient communication for medication deliveries
What Stays In-House
- Clinical sections of PAP applications (provider signatures, diagnosis codes, treatment justification)
- Patient-facing financial counseling conversations
- Prescribing decisions and medication management
Why India and the Philippines India and the Philippines are the leading destinations for healthcare BPO. Both countries offer large pools of college-educated, English-proficient professionals trained in US healthcare workflows. The 12-hour time zone offset from the US East Coast enables true 24-hour coverage. The global healthcare BPO market is valued at $423.1 billion in 2026 (MarketsandMarkets), and the US healthcare BPO market alone is $165.05 billion, growing at 8.26% CAGR (Mordor Intelligence).
State-Specific Drug Assistance: AZ, CO, and WA
Drug assistance rules vary by state. In Arizona, the AHCCCS prescription copayment is $2.30 and the Arizona Rx Card offers up to 80% discounts with no income requirement. Colorado’s State Drug Assistance Program (SDAP) serves HIV-positive residents at or below 500% of the federal poverty level, with renewal required each year during the patient’s birth month. Washington’s Prescription Drug Affordability Board selected drugs including Enbrel, Xtandi, Cabometyx, and Humira for 2025 affordability reviews, and caps insulin copays at $35 per month for state-regulated health plans.
How Staffingly Manages Drug Assistance Programs
Staffingly, Inc. provides dedicated drug assistance program management teams to 800+ US healthcare providers. Here is how the process works:
Workflow Assessment – Staffingly’s implementation team reviews your current PAP enrollment process, identifies your patient population’s medication mix, maps the assistance programs relevant to your practice, and documents your EHR and tracking system setup.
Dedicated Team Assembly – Based on your patient volume and drug assistance complexity, Staffingly builds a dedicated team trained on the specific PAPs, SPAPs, 340B rules, and state programs your practice uses.
Go-Live in 48-72 Hours – Your team begins screening patients, preparing applications, tracking submissions, and managing renewals within 48-72 hours of contract execution. This is not a shared queue. Your team works exclusively on your practice’s drug assistance workflow.
Daily Operations – Your Staffingly team handles eligibility screening, application preparation, document collection, submission tracking, denial follow-up, renewal management, shipment tracking, and daily reporting.
Clinical Oversight – Staffingly’s clinical review team, led by Bincy Kuriakose, MSN, RN (IL RN License #041.577729), provides oversight on clinical documentation questions, eligibility edge cases, and compliance matters.
Staffingly by the Numbers
- 800+ US healthcare providers served
- 99.2% clean claim rate
- $399/week (volume discounts to $299/week), fully managed
- 70% cost savings versus US-based staff
- 50+ EHR platforms supported
- 48-72 hour go-live
- SOC 2 Type II, HITRUST, ISO 27001, HIPAA compliant
FAQ
Q1: What are drug assistance programs? A: Drug assistance programs help patients afford prescription medications. They include manufacturer Patient Assistance Programs (PAPs) that provide free or low-cost brand-name drugs, the 340B Drug Pricing Program that offers discounted drugs to eligible healthcare organizations, copay assistance cards from manufacturers, State Pharmaceutical Assistance Programs (SPAPs), Medicare Extra Help (Low-Income Subsidy), and nonprofit foundation programs. Over 900 programs are searchable through the PhRMA Medicine Assistance Tool.
Q2: What are patient responsibilities in drug assistance programs? A: Patients must complete applications accurately with income documentation and proof of residency, renew enrollment annually with updated income verification, report changes in income or insurance status, submit out-of-pocket costs to Medicare Part D if enrolled, follow prescribed refill schedules, and understand copay card annual limits. Missing any of these steps can result in loss of benefits or gaps in medication access.
Q3: How much staff time does PAP enrollment require? A: A PMC survey found that 52.4% of practices spend 10-15 hours per week on PAP applications, and 18.8% of practices report that PAP work consumes more than half of the responsible staff member’s working hours. Each individual application averages about one hour of staff time per medication per patient per year. Outsourcing PAP management to Staffingly at $399/week (volume discounts to $299/week) frees clinical staff for patient care.
Q4: What is the 340B Drug Pricing Program? A: The 340B program, administered by HRSA, requires drug manufacturers to sell outpatient drugs at significant discounts to eligible covered entities including FQHCs, disproportionate share hospitals, and Ryan White grantees. In 2024, 340B purchases totaled $81.4 billion. The savings are intended to stretch scarce resources and expand services for low-income and uninsured patients. CMS is increasing oversight of 340B in 2026 with hospital acquisition cost surveys.
Q5: How does the IRA’s Part D redesign affect drug assistance programs in 2026? A: The Inflation Reduction Act capped Medicare Part D annual out-of-pocket costs at $2,100 for 2026, eliminated the donut hole as of 2025, and enabled drug price negotiations for 10 high-cost medications. The expanded Extra Help program now covers individuals up to 150% FPL. These changes reduce the need for some patients to use manufacturer PAPs but increase the complexity of determining which patients still need supplemental assistance.
Q6: Can drug assistance program management be outsourced? A: Yes. The administrative functions of PAP management — including eligibility screening, application preparation, document collection, submission tracking, denial follow-up, and renewal management — can be outsourced to a healthcare BPO partner. Staffingly provides dedicated PAP management teams at $399/week (volume discounts to $299/week) with 48-72 hour go-live, full HIPAA compliance, and training on manufacturer portals, state programs, and 340B rules.
Q7: What drug assistance programs are available in Arizona, Colorado, and Washington? A: Arizona offers AHCCCS Medicaid drug coverage ($2.30 copay), Arizona Rx Card (up to 80% discounts, no income requirement), and ADAP for HIV patients. Colorado has the State Drug Assistance Program (income up to 500% FPL for HIV patients), Bridging the Gap SPAP, and Health First Colorado Medicaid. Washington offers Apple Health Medicaid, a $35/month insulin copay cap, and the Prescription Drug Affordability Board that can set upper payment limits on unaffordable drugs.
Q8: How fast can Staffingly set up a drug assistance management team? A: Staffingly’s go-live time is 48-72 hours from contract execution. During that window, your dedicated team is assembled, trained on your specific PAPs, state programs, EHR, and tracking workflows, and begins screening patients and processing applications. This is not a shared service. Your team works exclusively on your practice’s drug assistance program management.
Ready to Cut Prior Authorization and Eligibility Headaches?
Staffingly helps practices like yours get paid faster with a 99.2% clean-claim rate, 65-70% cost savings, and 48-72 hour go-live. SOC 2 Type II, HITRUST, and ISO 27001 certified. HIPAA compliant. MGMA Corporate Member.
- Start a 15-Day Risk-Free Pilot and see results before you commit.
- Call us: (800) 489-5877
Frequently Asked Questions
Teams that handle drug assistance programs often pair them with upstream coverage and patient-support work. These services connect directly to the workflow described above:
- Charity Care Screening and Financial Assistance Services to qualify patients for help before balances age.
- Pre-Specialty-Drug Insurance Clearance to confirm coverage for high-cost specialty medications.
- Medication Adherence Outreach to keep enrolled patients on therapy and on top of renewals.
